Dr Will Singleterry | Director Of Business Development
IsoPlexis

Dr Will Singleterry, Director Of Business Development, IsoPlexis

Will Singleterry is a T Cell Immunologist who received his Doctoral Degree from the University of Mississippi Medical Center and completed his Post-Doctoral Training at St. Jude Children’s Research Hospital.  He now serves as the Director of Business Development for IsoPlexis, a venture capital-funded life sciences company dedicated to accelerating the fight against cancer through its single-cell proteomics platform.  Will manages the collaborations between IsoPlexis and their Bio-Pharmaceutical partners, using IsoPlexis’ single-cell technologies to reveal the highly functional cell subsets driving clinical response in Immunotherapy.

Appearances:



April 16 Day 2 - 10 Co-conferences @ 16:40

Single cell functionality serves as a predictive biomarker for overall survival of pancreatic cancer patients treated with GVAX vaccine

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071